Physician profile
Leon A Driss
NPI 1669445706
$5,728.50
in general payments reported to CMS, 2019-2025
33 companies · $265 in 2025
The $265 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,180 · 2020: $517 · 2021: $778 · 2022: $1,115 · 2023: $1,095 · 2024: $779 · 2025: $265.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,389 · Gift: $750.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,388.61 |
| Gift | $750.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sekisui Diagnostics LLC | $935.00 | 2022-2024 | |
| Novo Nordisk INC | $619.02 | 2019-2025 | Rybelsus, Ozempic |
| Flowonix Medical Incorporated | $546.59 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $520.99 | 2019-2025 | Airsupra, Breztri |
| Glaxosmithkline, LLC. | $375.99 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $335.61 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $249.73 | 2021-2024 | |
| Grifols USA, LLC | $228.04 | 2021-2023 | Prolastin-C Liquid |
| Lilly USA, LLC | $217.06 | 2020-2023 | Mounjaro, Jardiance |
| Abbvie INC. | $205.22 | 2021-2025 | Teflaro, Avycaz, Dalvance |
| Genentech USA, INC. | $194.02 | 2019-2024 | Xolair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $171.23 | 2019-2022 | |
| Amgen INC. | $120.56 | 2022-2025 | Evenity, Otezla, Repatha |
| Mylan Specialty L.P. | $112.78 | 2020-2024 | Yupelri |
| E.R. Squibb & Sons, L.L.C. | $104.68 | 2022-2024 | Eliquis |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $102.21 | 2021-2022 | |
| Recordati_rare_diseases_inc. | $81.34 | 2023-2025 | Isturisa, Signifor Lar |
| Acorda Therapeutics, INC | $80.32 | 2019-2020 | |
| Amarin Pharma, INC. | $78.78 | 2020-2021 | |
| Astellas Pharma US INC | $78.48 | 2023-2024 | Veozah |
| Merck Sharp & Dohme LLC | $48.85 | 2020-2022 | |
| Collegium Pharmaceutical, INC. | $47.69 | 2023-2024 | Xtampza |
| Biohaven Pharmaceutical Holding Company LTD. | $42.09 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $41.86 | 2021 | |
| Acadia Pharmaceuticals INC | $37.41 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $27.12 | 2019 | |
| Phathom Pharmaceuticals, INC. | $25.66 | 2025 | Voquezna |
| Argenx US, INC. | $19.22 | 2025 | Vyvgart Hytrulo |
| Shire North American Group INC | $19.01 | 2019 | |
| Digestive Care, INC. | $18.36 | 2024 | Pertzye |
| Alexion Pharmaceuticals, INC. | $17.26 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $13.91 | 2019 | |
| Alkermes, INC. | $12.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Leon Driss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.